Introduction:
South Asians develop type 2 diabetes (T2D) at younger ages. This study evaluated how age at T2D diagnosis impacts risks of all-cause mortality, cardiovascular (CVD) mortality, non-fatal CVD events, and years of life lost (YLL).
Methods:
- Population: 21,861 CARRS cohort participants.
- T2D Definition: Based on self-report, treatment, or lab criteria [Fasting blood glucose (FPG) ≥126 mg/dL, 2-hour post-meal glucose (2-h PG) >200 mg/dL, glycated hemoglobin (HbA1c) ≥6.5%].
- Groups by Age at Diagnosis: 20–29, 30–39, 40–59, ≥60 years.
- Analysis: Cox regression (adjusted for age, sex, BMI, smoking, education, BP, and cholesterol); YLL calculated using India’s Individual Annuitant Mortality Table.
Results:
- T2D Prevalence: 6,396 participants (5,295 prevalent; 181 incident).
- Follow-up: 132,293 person-years over 14 years.
- Outcomes: 2,121 deaths (809 from CVD); 336 non-fatal CVD events.
Outcome |
No diabetes, n=15,465 |
T2D 20–29y,n=268 (4.2%) |
T2D 30–39n=1,194 (18.7%) |
T2D 40–59y, n=3,831 (59.9%) |
T2D ≥60y, n=1,103 (17.2%) |
Total Mortality |
|||||
No. of events |
951 |
15 |
109 |
617 |
429 |
Mortality rate (/1000 PY) |
10.7 |
8.4 |
13.2 |
23.4 |
59.8 |
HR [95% CI]a |
Ref |
2.0 [1.7–2.3] |
1.9 [1.7–2.1] |
1.4 [1.3–1.5] |
1.1 [1.0–1.1] |
HR [95% CI]b |
Ref |
2.2 [1.2–3.8] |
2.0 [1.6–2.5] |
1.4 [1.2–1.6] |
0.9 [0.8–1.1] |
CVD Mortality |
|||||
No. of events |
278 |
3 |
46 |
297 |
185 |
Mortality rate (/1000 PY) |
3.1 |
1.7 |
5.6 |
11.3 |
25.8 |
HR [95% CI]a |
Ref |
2.7 [2.2–3.4] |
3.1 [2.7–3.6] |
2.2 [2.0–2.3] |
1.3 [1.2–1.5] |
HR [95% CI]b |
Ref |
1.9 [0.6–6.0] |
2.7 [1.9–4.0] |
2.1 [1.7–2.5] |
1.1 [0.9–1.4] |
Non-fatal CVD Events |
|||||
No. of events |
130 |
3 |
25 |
132 |
46 |
Incidence rate (/1000 PY) |
1.5 |
1.7 |
3.1 |
5.1 |
6.4 |
HR [95% CI]a |
Ref |
2.4 [1.7–3.4] |
2.1 [1.6–2.7] |
2.3 [2.0–2.6] |
1.4 [1.1–1.8] |
HR [95% CI]b |
Ref |
1.3 [0.3–5.5] |
2.4 [1.5–3.9] |
2.1 [1.6–2.8] |
1.1 [0.7–1.7] |
PY = person-years; HR = hazard ratio; CVD = cardiovascular disease a: Adjusted for age and sex, b: Adjusted for age, sex, education, smoking, BMI, systolic blood pressure, and total cholesterol
Conclusion:
Younger age at T2D onset is associated with higher risks of all-cause and CVD mortality, non-fatal CVD events, and more life years lost. The burden is greatest for those diagnosed before age 40, emphasizing the need for early detection and management in South Asians.
ADA 2025, 20-23 June, Chicago